Sumoylation: a regulatory protein modification in health and disease

A Flotho, F Melchior - Annual review of biochemistry, 2013 - annualreviews.org
Posttranslational modification with small ubiquitin-related modifier (SUMO) proteins is now
established as one of the key regulatory protein modifications in eukaryotic cells. Hundreds …

Insights in post-translational modifications: ubiquitin and SUMO

D Salas-Lloret, R González-Prieto - International Journal of Molecular …, 2022 - mdpi.com
Both ubiquitination and SUMOylation are dynamic post-translational modifications that
regulate thousands of target proteins to control virtually every cellular process …

NPM1/B23: a multifunctional chaperone in ribosome biogenesis and chromatin remodeling

MS Lindström - Biochemistry research international, 2011 - Wiley Online Library
At a first glance, ribosome biogenesis and chromatin remodeling are quite different
processes, but they share a common problem involving interactions between charged …

Divorcing ARF and p53: an unsettled case

CJ Sherr - Nature Reviews Cancer, 2006 - nature.com
Mammalian cells that sustain oncogenic insults can invoke defensive programmes that
either halt their division or trigger their apoptosis, but these countermeasures must be finely …

Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases

E Colombo, M Alcalay, PG Pelicci - Oncogene, 2011 - nature.com
Nucleophosmin (NPM, also known as B23, numatrin or NO38) is a ubiquitously expressed
phosphoprotein belonging to the nucleoplasmin family of chaperones. NPM is mainly …

SUMO E3 ligase activity of TRIM proteins

Y Chu, X Yang - Oncogene, 2011 - nature.com
SUMOylation governs numerous cellular processes and is essential to most eukaryotic life.
Despite increasing recognition of the importance of this process, an extremely limited …

Classical and novel prognostic markers for breast cancer and their clinical significance

P Taneja, D Maglic, F Kai, S Zhu… - Clinical Medicine …, 2010 - journals.sagepub.com
The use of biomarkers ensures breast cancer patients receive optimal treatment.
Established biomarkers such as estrogen receptor (ER) and progesterone receptor (PR) …

Therapeutic potential of targeting the SUMO pathway in cancer

A Kukkula, VK Ojala, LM Mendez, L Sistonen… - Cancers, 2021 - mdpi.com
Simple Summary The small ubiquitin-like modifier (SUMO) pathway regulates the hallmark
properties of cancer cells. Moreover, alterations in activity and in levels of SUMO machinery …

It's getting complicated—a fresh look at p53-MDM2-ARF triangle in tumorigenesis and cancer therapy

CP Kung, JD Weber - Frontiers in cell and developmental biology, 2022 - frontiersin.org
Anti-tumorigenic mechanisms mediated by the tumor suppressor p53, upon oncogenic
stresses, are our bodies' greatest weapons to battle against cancer onset and development …

The structure and functions of NPM1/Nucleophsmin/B23, a multifunctional nucleolar acidic protein

M Okuwaki - Journal of biochemistry, 2008 - academic.oup.com
Abstract NPM1/Nucleophosmin/B23, also termed NO38 or numatrin, is an acidic nucleolar
protein that plays multiple roles in cell growth and proliferation. In general, the expression …